Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06294626
Other study ID # ISozeri
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date December 31, 2023

Study information

Verified date February 2024
Source Acibadem Atunizade Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

It's an observational study. Purpose of the study: To evaluate the neuromotor development of scaphocephaly cases. 21 infants diagnosed with scaphocephaly aged 2-17 months were included. - Is there any delay in the neuromotor development of scaphocephaly cases? - If delay is observed, in which area is it most common? Denver-II Developmental Screening Test and Alberta Motor Infant Scale were applied to the participants.


Description:

Scaphocephaly (sagittal synostosis) is the most common single-suture craniosynostosis. It occurs as a result of premature ossification of the fibrous connective tissue extending between two parietal bones (sagittal suture). Phenotypically, a long and narrow head shape occurs. It occurs in 2-3 per 10,000 live births and is more common in men. Premature ossification of the sagittal suture can lead to cranial deformity, potentially cranial growth restriction, and resulting increased intracranial pressure. In these cases, increased intracranial pressure and compression of the sagittal sinus cause increased venous pressure, which may cause developmental delays. These delays most commonly include cognitive impairments, language disorders, motor delays, learning disabilities, executive dysfunction, and behavioral problems. When looking at the literature, it was seen that the studies were mostly on neurocognitive development in cases with craniosynostosis. There are relatively fewer studies focusing on the neuromotor development of these cases. This study aims to evaluate the neuromotor development of scaphocephaly cases.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 2 Months to 17 Months
Eligibility Inclusion Criteria: - Having been diagnosed with scaphocephaly - Being between 0-18 months Exclusion Criteria: - Be over 18 months - Having a diagnosed disease other than scaphocephaly

Study Design


Intervention

Other:
Group 1
21 cases with scaphocephaly diagnoses were included. Neuromotor development was evaluated with the Denver-II Developmental Screening Test and Alberta Infant Motor Scale.

Locations

Country Name City State
Turkey Acibadem Altunizade Hospital Istanbul Uskudar

Sponsors (1)

Lead Sponsor Collaborator
Acibadem Atunizade Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Denver-II Developmental Screening Test It's a screening test used in children aged 0-6 years. The test is done in a short time like 5-20 min. The person who will administer the Denver-II test; must be trained and certified. Standardized test materials are used. The test consists of 4 sections and 134 items. There are personal-social, language, fine motor and gross motor sections. The test result is classified as Normal-Abnormal-Suspicious. baseline
Primary Alberta Infant Motor Scale It's used to observe gross motor functions and evaluate the effectiveness of the intervention in typically developing infants between 0-18 months. The duration of the test is 10 min and consists of 58 items. The child's spontaneous movements are evaluated in 4 different positions without touching the child. 1 point is taken for each item that can be done. A table containing the mean and standard deviation for each month is used. The test result is classified as Normal-Abnormal-Suspicious. baseline
See also
  Status Clinical Trial Phase
Completed NCT06052410 - Early Intervention in Children at Risk of Developmental Delay N/A
Not yet recruiting NCT06458959 - Exploratory Trial of a Pediatric Web-Based Care Planning Guide N/A
Recruiting NCT04518332 - Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.
Active, not recruiting NCT02000284 - Mitochondrial Dysfunction in Autism Spectrum Disorder
Recruiting NCT05527080 - Development of Motility and Cognition in Infants
Recruiting NCT04672967 - MAP Autism Prediction Study
Completed NCT02712853 - Improving Autism Screening With Brain-Related miRNA
Completed NCT01975506 - Occupational Therapy in the Context of Head Start N/A
Completed NCT01253083 - Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot Study Phase 1
Not yet recruiting NCT05605977 - Home-based Visual-motor Training Program on Kindergarteners N/A
Completed NCT05408351 - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Completed NCT02832557 - A Salivary miRNA Diagnostic Test for Autism
Recruiting NCT02769949 - Pediatric Patients With Metabolic or Other Genetic Disorders
Active, not recruiting NCT02813889 - SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants N/A
Completed NCT02115334 - Development and Effectiveness of Home-based Programs for Preschool Children With Developmental Delay N/A
Completed NCT01351077 - CHICA Developmental Screening Study N/A
Recruiting NCT06461572 - Effects of Power Ball on Proximal Muscle and Refractive Errors in Developmental Delay. N/A
Suspended NCT03307317 - Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
Completed NCT03223688 - Early Intervention for Developmental Delay N/A
Completed NCT02141802 - Clinical Effectiveness of Increased Standing Time in Non-ambulant Children With Cerebral Palsy:a Pilot Study N/A